Treatment Approaches for Triple-Positive mBC in the 2L Setting and Beyond

Opinion
Video

Susan Dent, MD, delves into treatment approaches for triple-positive breast cancer in the second-line and beyond, highlighting findings from the DESTINY-Breast03 trial.

Recent Videos
4 experts in this video
4 experts in this video
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
4 experts in this video
4 experts in this video
5 experts in this video
4 experts in this video
4 experts in this video
Related Content